BPA Levels Relationship With IVF/ICSI Outcomes in Low Ovarian Reserve
Primary Purpose
Infertility Low Over Reserve, IVF, Infertility, Female
Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
BPA levels
Sponsored by
About this trial
This is an interventional supportive care trial for Infertility Low Over Reserve
Eligibility Criteria
Inclusion Criteria:
- patients who underwent IVF due to low ovarian reserve
- patients provided urine, blood, and follicle fluid (FF) samples on the oocyte retrieval day
- patients who did not smoke or use alcohol
- patients did not work in the plastic industry
Exclusion Criteria:
- patients who underwent IVF due to unexplained infertility or tubal factor or male factor indications
- patients diagnosed with endometriosis
- patients with freeze-all cycles
- patients having previous ovarian surgery
- women with metabolic disease (such as hypertension or diabetes mellitus)
- patients with a known genetic problem (male or female)
Sites / Locations
- Nefise Nazlı YENIGUL
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
BPA level
Arm Description
BPA (bisphenol A) in urine, blood and follicle fluid samples
Outcomes
Primary Outcome Measures
Exposure to BPA
Concentrations of Bisphenol A (BPA) will be quantified in the urine, blood plasma, and follicular fluid (individual and pooled samples) by use of ELİSA test in women with low ovarian reserve
Secondary Outcome Measures
Full Information
NCT ID
NCT04654598
First Posted
November 27, 2020
Last Updated
December 10, 2020
Sponsor
Nefise Nazlı YENIGUL
1. Study Identification
Unique Protocol Identification Number
NCT04654598
Brief Title
BPA Levels Relationship With IVF/ICSI Outcomes in Low Ovarian Reserve
Official Title
Could the Consumption of Water From Plastic Bottles Affect the Embryo Grade and Clinical Pregnancy Rate Obtained With IVF/ICSI in Low Ovarian Reserve
Study Type
Interventional
2. Study Status
Record Verification Date
December 2020
Overall Recruitment Status
Completed
Study Start Date
April 1, 2019 (Actual)
Primary Completion Date
September 30, 2019 (Actual)
Study Completion Date
September 30, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Nefise Nazlı YENIGUL
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The relationship between BPA elevation in urine, blood, and follicle fluid and embryo quality, IVF/ICSI outcomes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility Low Over Reserve, IVF, Infertility, Female
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
74 (Actual)
8. Arms, Groups, and Interventions
Arm Title
BPA level
Arm Type
Other
Arm Description
BPA (bisphenol A) in urine, blood and follicle fluid samples
Intervention Type
Other
Intervention Name(s)
BPA levels
Intervention Description
BPA (bisphenol A) in urine, blood and follicle fluid samples
Primary Outcome Measure Information:
Title
Exposure to BPA
Description
Concentrations of Bisphenol A (BPA) will be quantified in the urine, blood plasma, and follicular fluid (individual and pooled samples) by use of ELİSA test in women with low ovarian reserve
Time Frame
6 month
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
patients who underwent IVF due to low ovarian reserve
patients provided urine, blood, and follicle fluid (FF) samples on the oocyte retrieval day
patients who did not smoke or use alcohol
patients did not work in the plastic industry
Exclusion Criteria:
patients who underwent IVF due to unexplained infertility or tubal factor or male factor indications
patients diagnosed with endometriosis
patients with freeze-all cycles
patients having previous ovarian surgery
women with metabolic disease (such as hypertension or diabetes mellitus)
patients with a known genetic problem (male or female)
Facility Information:
Facility Name
Nefise Nazlı YENIGUL
City
Sanlıurfa
Country
Turkey
12. IPD Sharing Statement
Learn more about this trial
BPA Levels Relationship With IVF/ICSI Outcomes in Low Ovarian Reserve
We'll reach out to this number within 24 hrs